Abstract
This study was designed to determine the effects of antiarrhythmic agents on global left ventricular (LV) function during exercise in patients with chronic LV dysfunction. Thirty-five patients with LV dysfunction [LV ejection fraction (LVEF) < 45%] and ventricular arrhythmias were studied. They were randomly classified into 3 groups: patients who received a single oral dose of 6 mg/kg disopyramide phosphate (n = 12), those who received a single oral dose of 4 mg/kg mexiletine hydrochloride (n = 12), and those who received a single oral dose of 4 mg/kg pilsicainide hydrochloride (n = 11). First, all patients were subjected to baseline rest and peak exercise, equilibrium-gated cardiac-pool scintigraphy with 99mTc-human serous albumin of 740 MBq (baseline data). Second, on a separate day, they were given drugs once, and were subsequently subjected to rest and peak exercise equilibrium-gated cardiac-pool scintigraphy. Exercise LVEF and peak ejection rate (PER) after administration were significantly lower in the disopyramide and pilsicainide groups than in the mexiletine group (p < 0.05, respectively). The changes in LVEF and PER from rest to peak exercise after administration were significantly less than the baseline changes in th...Continue Reading
References
Jun 1, 1977·British Journal of Clinical Pharmacology·I D BradbrookH J Rogers
Dec 1, 1977·Circulation·J A Udall, M H Ellestad
Jan 1, 1992·Cardiology·A HartmannM Kaltenbach
Mar 21, 1991·The New England Journal of Medicine·D S EchtH L Greene
Oct 1, 1985·Circulation Research·S S Sheu, W J Lederer
Aug 10, 1989·The New England Journal of Medicine·UNKNOWN Cardiac Arrhythmia Suppression Trial (CAST) Investigators
Nov 1, 1989·American Heart Journal·S S Gottlieb
Aug 1, 1989·Clinical Cardiology·R F PercyA B Miller
Mar 1, 1988·The American Journal of Cardiology·UNKNOWN Cardiac Arrhythmia Pilot Study (CAPS) Investigators
Jan 1, 1987·Journal of the American College of Cardiology·A A de PaolaH R Kay
May 1, 1987·The American Journal of Cardiology·M A KonstamD N Salem
Nov 1, 1974·Journal of Clinical Pharmacology·J M Samet, B Surawicz
Apr 1, 1973·The American Journal of Cardiology·H BlackburnR D Thorsen
Aug 1, 1974·Clinical Pharmacology and Therapeutics·L A VismaraE A Amsterdam
Mar 1, 1966·American Heart Journal·W G Nayler
Apr 1, 1984·Journal of Clinical Pharmacology·E M Vaughan Williams
Jan 1, 1981·European Journal of Nuclear Medicine·P T MaklerJ F Spann
May 15, 1983·The American Journal of Cardiology·J S GottdienerR D Fletcher
Sep 1, 1983·The American Journal of Cardiology·M H SamiR Lisbona
May 1, 1984·The American Journal of Cardiology·G WisenbergB Gryfe-Becker
Aug 27, 1982·Deutsche medizinische Wochenschrift·H A Wester, N Mouselimis
Apr 1, 1982·Circulation·B M MassieS G Henderson
Mar 13, 1980·The New England Journal of Medicine·P J PodridB Lown
Dec 1, 1994·Circulation·J L AndersonP E Carson
Jan 1, 1996·Journal of Cardiovascular Pharmacology·Y KiharaS Sasayama
Jun 1, 1960·The American Journal of Cardiology·E T ANGELAKOS, E P HASTINGS